Tufail M, Jiang C, Li N
Mil Med Res. 2025; 12(1):7.
PMID: 39934876
PMC: 11812268.
DOI: 10.1186/s40779-025-00595-2.
Linke J, Munn L, Jain R
Nat Rev Cancer. 2024; 24(11):768-791.
PMID: 39390249
DOI: 10.1038/s41568-024-00745-z.
Karancsi Z, Gregus B, Krenacs T, Cserni G, Nagy A, Szocs-Trinfa K
Int J Mol Sci. 2024; 25(17).
PMID: 39273393
PMC: 11394775.
DOI: 10.3390/ijms25179445.
Mierke C
Cells. 2024; 13(1).
PMID: 38201302
PMC: 10777970.
DOI: 10.3390/cells13010096.
Hui E, Sumey J, Caliari S
Mol Syst Des Eng. 2022; 6(9):670-707.
PMID: 36338897
PMC: 9631920.
DOI: 10.1039/d1me00049g.
Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer.
Wu Y, Yu S, Qiao H
Front Pharmacol. 2022; 13:990445.
PMID: 36120342
PMC: 9474995.
DOI: 10.3389/fphar.2022.990445.
Anti-tumor effects of PEGylated-nanoliposomes containing ginger extract in colorectal cancer-bearing mice.
Yavari M, Jaafari M, Mirzavi F, Mosayebi G, Ghazavi A, Ganji A
Iran J Basic Med Sci. 2022; 25(7):890-896.
PMID: 36033959
PMC: 9392564.
DOI: 10.22038/IJBMS.2022.63870.14075.
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses.
Lan Y, Yeung T, Huang H, Wegener A, Saha S, Toister-Achituv M
J Immunother Cancer. 2022; 10(7).
PMID: 35858707
PMC: 9305820.
DOI: 10.1136/jitc-2021-004122.
miR-135a Targets SMAD2 to Promote Osteosarcoma Proliferation and Migration.
Chen Y, Cai B, Lian X, Xu J, Zhang T
J Oncol. 2022; 2022:3037348.
PMID: 35466322
PMC: 9020941.
DOI: 10.1155/2022/3037348.
Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.
Pandit A, Begum Y, Saha P, Srivastava A, Swarnakar S
Front Oncol. 2022; 11:720622.
PMID: 35145899
PMC: 8821656.
DOI: 10.3389/fonc.2021.720622.
Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy.
Jensen C, Nissen N, Arenstorff C, Karsdal M, Willumsen N
J Exp Clin Cancer Res. 2021; 40(1):326.
PMID: 34656158
PMC: 8520279.
DOI: 10.1186/s13046-021-02133-z.
Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application.
Parakasikron N, Chaotham C, Chanvorachote P, Vinayanuwattikun C, Buranasudja V, Taweecheep P
Drug Deliv. 2021; 28(1):1443-1454.
PMID: 34236266
PMC: 8274507.
DOI: 10.1080/10717544.2021.1943055.
Functions of Thrombospondin-1 in the Tumor Microenvironment.
Kaur S, Bronson S, Pal-Nath D, Miller T, Soto-Pantoja D, Roberts D
Int J Mol Sci. 2021; 22(9).
PMID: 33925464
PMC: 8123789.
DOI: 10.3390/ijms22094570.
Complexity in regulating microRNA biogenesis in cancer.
Chen P, Lin S, Tsai S
Exp Biol Med (Maywood). 2020; 245(5):395-401.
PMID: 32075432
PMC: 7082889.
DOI: 10.1177/1535370220907314.
Cannabinoids in the Pathophysiology of Skin Inflammation.
Scheau C, Badarau I, Mihai L, Scheau A, Costache D, Constantin C
Molecules. 2020; 25(3).
PMID: 32033005
PMC: 7037408.
DOI: 10.3390/molecules25030652.
Plasma Membrane Ca ATPase Isoform 4 (PMCA4) Has an Important Role in Numerous Hallmarks of Pancreatic Cancer.
Sritangos P, Pena Alarcon E, James A, Sultan A, Richardson D, Bruce J
Cancers (Basel). 2020; 12(1).
PMID: 31963119
PMC: 7016988.
DOI: 10.3390/cancers12010218.
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
Nagesh P, Chowdhury P, Hatami E, Kumari S, Kashyap V, Tripathi M
ACS Appl Mater Interfaces. 2019; 11(42):38537-38554.
PMID: 31553876
PMC: 8020616.
DOI: 10.1021/acsami.9b14738.
Increased Risk of Cancer in Men With Peyronie's Disease: A Cohort Study Using a Large United States Insurance Claims Database.
Pastuszak A, Thirumavalavan N, Kohn T, Lipshultz L, Eisenberg M
Sex Med. 2019; 7(4):403-408.
PMID: 31530474
PMC: 6963113.
DOI: 10.1016/j.esxm.2019.08.007.
The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection.
Vicente-Munuera P, Burgos-Panadero R, Noguera I, Navarro S, Noguera R, Escudero L
Int J Cancer. 2019; 146(2):553-565.
PMID: 31173338
PMC: 6899647.
DOI: 10.1002/ijc.32495.
Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).
Cui X, Shang S, Lv X, Zhao J, Qi Y, Liu Z
Mol Med Rep. 2019; 19(6):5053-5062.
PMID: 31059090
PMC: 6522871.
DOI: 10.3892/mmr.2019.10209.